Because the level of hs‐cTnT can be affected by many comorbid conditions, we suggest the prediction model should be applied on an individual basis, weighing age, comorbidities, stroke severity, location of lesions, stroke etiology, and bleeding risk. This evidence concerns the gene TNNT2 and Stroke.